1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,161 | 0,321 | 07.10. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.09. | NEEM S HILL AB: Neem's Hill - Building the Next Chapter | 1 | Cision News | ||
| 22.09. | Neem's Hill AB: Neem's Hill - Building the Next Chapter | 165 | GlobeNewswire (Europe) | Neem's Hill AB (publ) provides a shareholder update on the Group's development, highlighting an installed base now exceeding 60 vetIQure systems and more than 4,500 Animal Care treatments sold.FROM... ► Artikel lesen | |
| 11.08. | NEEM S HILL AB: Neem's Hill AB (publ) publishes Interim report Q2 2026 | 1 | Cision News | ||
| 11.08. | Neem's Hill AB: Neem's Hill AB (publ) publishes Interim report Q2 2026 | 605 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website
January - June 2026
Net sales amounted to 6,090 KSEK (6,313)
Profit/loss after financial... ► Artikel lesen | |
| 13.07. | Neem's Hill AB: Scandinavian ChemoTech AB changes name to Neem's Hill AB | 331 | GlobeNewswire (Europe) | Former Scandinavian ChemoTech AB, has completed the name change to Neem's Hill AB ("Neem's Hill" or "the Company"), which was resolved at the Annual General Meeting held on 5 May 2026. The name change... ► Artikel lesen | |
| 10.07. | Change of issuer name for Scandinavian ChemoTech AB | 451 | GlobeNewswire | As from July 13, 2026, Scandinavian ChemoTech AB will change issuer name
Company name is Neem's Hill AB.
Old issuer name: Scandinavian ChemoTech AB
New issuer name: Neem's Hill AB
New... ► Artikel lesen | |
| NEEMS HILL Aktie jetzt für 0€ handeln | |||||
| 02.06. | Scandinavian ChemoTech AB: Scandinavian ChemoTech secures SEK 6 million Growth Loan from a larger Swedish Financial Institution | 237 | GlobeNewswire (Europe) | Scandinavian ChemoTech has secured a SEK 6 million growth loan from a larger financial institution in Sweden.
The financing forms part of ChemoTech's long-term financial strategy and will support the... ► Artikel lesen | |
| 28.04. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim report Q1 2026 | 353 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website January - March 2026
Net sales amounted to 2,798 KSEK (2,472)
Profit/loss after... ► Artikel lesen | |
| 07.04. | Scandinavian ChemoTech AB: ChemoTech's Proposed Strategic Changes Accepted by Nasdaq First North | 261 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) (the "Company") today announces that, based on information disclosed in the Company's press releases published on Tuesday, March 31, ahead of the notice of the Annual... ► Artikel lesen | |
| 01.04. | Scandinavian ChemoTech AB: Scandinavian ChemoTech Starts 2026 Strong with Best First Quarter in Company History | 265 | GlobeNewswire (Europe) | Scandinavian ChemoTech's Animal Care continues its strong commercial momentum, delivering its best first quarter in the company's history in Q1 2026, with sales amounting to approx. 299,000 USD compared... ► Artikel lesen | |
| 31.03. | Scandinavian ChemoTech AB: Scandinavian ChemoTech proposes expanded business activities, name change & received proposal on directed issue | 357 | GlobeNewswire (Europe) | NOT FOR DISCLOSURE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND... ► Artikel lesen | |
| 17.02. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Year-end report 2025 | 345 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website.
October - December 2025
Net sales amounted to 2,648 KSEK (2,041)
Profit/loss after... ► Artikel lesen | |
| 05.01. | Scandinavian ChemoTech AB: New Year's Letter to Shareholders in Scandinavian ChemoTech - Reflecting on 2025 | 484 | GlobeNewswire (Europe) | Dear Shareholders,
As we enter 2026, I would like to thank you for your continued trust and support of Scandinavian ChemoTech. The past year, 2025, has been an important one for the Company, a year... ► Artikel lesen | |
| 04.11.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q3 2025 | 291 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website.
July - September 2025 ... ► Artikel lesen | |
| 17.10.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Surpasses 3,000 Treatments Performed Worldwide | 323 | GlobeNewswire (Europe) | Scandinavian ChemoTech's Animal Care, a pioneer in making oncology care more compassionate and human for animals, proudly announces another achievement: over 3,000 treatments have now been performed... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 37,420 | -6,85 % | EQS-Adhoc: Fresenius Medical Care AG: Wechsel im Vorstandsvorsitz - Shervin J. Korangy folgt auf Helen Giza | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Personalentscheidungen / Vorstand
Fresenius Medical Care AG: Wechsel im Vorstandsvorsitz - Shervin J. Korangy folgt auf Helen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,560 | +1,29 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 43,285 | -1,12 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius erwirbt verbleibende 45 % an mAbxience für bis zu 750 Mio. € und erhält vollständige Kontrolle über seine Biosimilars-Plattform | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Strategische Unternehmensentscheidung
Fresenius erwirbt verbleibende 45 % an mAbxience für bis zu 750 Mio. € und erhält vollständige... ► Artikel lesen | |
| PROGYNY | 27,550 | 0,00 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| BRIGHTSPRING HEALTH SERVICES | 63,84 | +0,06 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| HEARTFLOW | 49,335 | -0,05 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,540 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Expands to Three New California Counties and Adds Hoag and Astrana Health for 2027 | ||
| KESTRA MEDICAL TECHNOLOGIES | 26,490 | 0,00 % | Piper Sandler reiterates Kestra Medical stock rating on patent potential | ||
| CARL ZEISS MEDITEC | 31,820 | +2,12 % | 200-Tage-Linie hält: Goldman verpasst Zeiss Meditec einen Dämpfer | Goldman Sachs stuft Carl Zeiss Meditec auf "Sell" ab und senkt das Kursziel auf 23 Euro. Zwischenzeitlich verlor das Papier gut sieben Prozent, fing sich dann aber knapp über der 200-Tage-Linie. Die... ► Artikel lesen | |
| BILLIONTOONE | 95,70 | -0,05 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,310 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| GENEDX | 68,48 | -0,07 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| PROCEPT BIOROBOTICS | 17,920 | +0,06 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
| DRAEGERWERK | 113,00 | -2,42 % | Drägerwerk-Aktie // Dicker Freudensprung | Bei Drägerwerk läuft das Geschäft weiterhin sehr gut. Dies belegen überzeugende Zahlen für das erste Halbjahr. So erhöhte sich der Umsatz um 6,2 Prozent auf rund 1,6 Milliarden Euro. Bereinigt wäre... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,135 | +0,21 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call |
Das Unternehmen NEEMS HILL AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,191 Euro und damit +6,11 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEEMS HILL AB finden Sie auf Wallstreet Online.